Parameter | Dose of SB-277011-A (μg/kg) | ||||||||
---|---|---|---|---|---|---|---|---|---|
0 | 10 | 20 | 40 | 80 | 160 | 320 | 640 | 1280 | |
Spikes/burst2-a | 3.0 ± 0.5 | 2.9 ± 0.5 | 3.0 ± 0.5 | 3.0 ± 0.4 | 2.7 ± 0.6 | 2.6 ± 0.6 | 2.9 ± 0.4 | 3.1 ± 0.6 | 2.9 ± 0.5 |
Interspike interval (ms)2-a | 178 ± 11 | 175 ± 13 | 177 ± 10 | 179 ± 15 | 184 ± 12 | 194 ± 13 | 190 ± 13 | 186 ± 14 | 193 ± 17 |
Percentage of events as bursts2-b | 36 | 38 | 35 | 36 | 34 | 32 | 35 | 40 | 38 |
Coefficient of variation2-a | 69 ± 12 | 70 ± 13 | 67 ± 12 | 69 ± 13 | 65 ± 12 | 66 ± 13 | 66 ± 12 | 69 ± 13 | 67 ± 13 |
A total of nine neurons were examined at each dose. At the dose of 640 μg/kg, one of nine neurons being recorded was lost as were two of nine neurons at the 1280-μg/kg dose, i.e., an action potential for a DA neuron could no longer be detected. SB-277011-A was given i.v. in a cumulative fashion.